Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Latanoprost versus timolol in pediatric glaucoma
2007-004543-30Phase 3Completed
- Sponsor
- Pfizer
- Start
- Nov 2007
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Childhood Glaucoma and Buphthalmos (CG) comparing Latanoprost arm with Timolol arm (2 arms). Started Nov 2007; status: completed.
02
Drugs
latanoprosttimolol
03
Conditions
Childhood GlaucomaBuphthalmos (CG)
Beyond the preview
Go deeper on 2007-004543-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004543-30.